Latitude Pharmaceuticals (United States)

Latitude Pharmaceuticals (United States)

Open Access statistics for Latitude Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024.

Open Access statistics for Latitude Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

75%


Total
Publications

57


Total Open
Publications

43


Total
Citations

2.7K


Open Access
Percentage

75%


Total
Publications

57


Total Open
Publications

43


Total
Citations

2.7K

Website

download

Breakdown

51% 12% 12% 25%

Publisher Open

51%

Both

12%

Other Platform Open

12%

Closed

25%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

012345678910Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

25%OA Journal

OA Journal 25%

9

Hybrid 31%

11

No Guarantees 44%

16

Other Platform Open

Institution 50%

7

Other Internet 50%

7

Preprint 14%

2

Domain 14%

2

Public 7%

1

Other Platform Locations

Name

Platform Type

Publications

University of Birmingham - University of Birmingham Research Portal
Institution
4
Ecole Polytechnique Fédérale de Lausanne - Infoscience
Institution
4
Radboud University - Radboud Repository
Institution
3
Unknown Repository
Other Internet
2
University of Malta - OAR@UM
Institution
2
University of Jyväskylä - Jyväskylä University Digital Archive
Institution
2
University of Ferrara - Institutional Research Information System University of Ferrara
Institution
2
University of Copenhagen - Research at the University of Copenhagen
Institution
2
University of Bath - University of Bath Research Portal
Institution
2
unipi.it OAI-PMH Repository
Institution
2
1 / 7

Data updated 7 April 2025

Share

Share

Share